The Molecular Profiling Lottery: More Accuracy, Less Precision, and No Cost

The concept of complete molecular profiling to select investigational treatment options is appealing, theoretically allowing the matching of patients to investigational drugs specifically targeted to molecular features of each patient's cancer. Although some patients do benefit from such a strategy, the vast majority do not.

See related article by Tuxen et al., p. 1239

http://bit.ly/2tmYkpm